Respiratory Syncytial Virus Infection Clinical Trials

39 clinical trials for Respiratory Syncytial Virus Infection across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals — RECRUITING · PHASE2
• A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children — RECRUITING · PHASE3
• Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus ) — RECRUITING
• A clinical trial of RV521 in healthy volunteers — COMPLETED · PHASE2
• A Study of AK0529 in infants with Respiratory Syncytial Virus Infection — COMPLETED · PHASE2
• An RSV Human Challenge Study of Palivizumab in Healthy Adult Participants — OTHER · PHASE2
• Phase 2a Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults — OTHER · PHASE2
• A Study of ALS-008176 in Infants and Children Hospitalized with RSV — TERMINATED · PHASE2
• The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products — COMPLETED · PHASE4
• Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older — COMPLETED · PHASE1
• Risk Factors and Severity of Bronchiolitis in Hospitalized Children at Assiut University Hospital — NOT_YET_RECRUITING
• Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate — COMPLETED · PHASE1
• Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older — COMPLETED · PHASE2
• Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants — NOT_YET_RECRUITING
• Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004) — COMPLETED · PHASE2
• SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER — ACTIVE_NOT_RECRUITING
• Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA) — COMPLETED · PHASE1
• RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV — NOT_YET_RECRUITING
• A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection — TERMINATED · PHASE2
• Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older — COMPLETED · PHASE1
• Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers — COMPLETED · PHASE1
• Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV — COMPLETED · PHASE2
• A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults. — COMPLETED · PHASE1
• A clinical study of MK-3508 in healthy people (MK-3508-006) — OTHER · PHASE1
• Molecular and Microbiome/Metagenome Correlates of Recurrent Wheeze in RSV Infected Infants — COMPLETED
• A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults — COMPLETED · PHASE1
• A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171 — COMPLETED · PHASE1
• Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection — COMPLETED · PHASE2
• Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract — COMPLETED · PHASE2
• ALX-0171 Safety Study in Adults With Hyperresponsive Airways — COMPLETED · PHASE1
• Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis® — COMPLETED
• Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children — COMPLETED
• Surveillance of Synagis in Korean Pediatric Patients — COMPLETED
• A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America — COMPLETED
• Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions — COMPLETED · PHASE3
• Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection — COMPLETED
• Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children — COMPLETED · PHASE2
• Prevention of RSV Infections in Bone Marrow Transplant Recipients — COMPLETED · PHASE4

Refine this search